Skip Navigation


IJE Advance Access originally published online on December 20, 2005
International Journal of Epidemiology 2006 35(2):352-353; doi:10.1093/ije/dyi293
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
35/2/352    most recent
dyi293v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (11)
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Glezen, W P.
Right arrow Articles by Simonsen, L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Glezen, W P.
Right arrow Articles by Simonsen, L.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Published by Oxford University Press on behalf of the International Epidemiological Association © The Author 2005; all rights reserved.

Commentary

Commentary: Benefits of influenza vaccine in US elderly—new studies raise questions

W Paul Glezen1,* and Lone Simonsen2

1 Department of Molecular Virology and Microbiology, and Pediatrics, Baylor College of Medicine, Houston, TX, USA
2 Office of Global Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA

* Corresponding author. MVM Department, Baylor College of Medicine, One Baylor Plaza, MS:BCM-280, Houston, TX 77030, USA. E-mail: wglezen@bcm.edu

The first 10% of the full text of this article appears below.

During the period from 1989 to 1997 the vaccination rate for elderly persons ≥65 years of age in the US increased from 30 to 67%. Despite this increase in coverage, mortality and hospitalization rates continued to increase rather than decline as would be expected if the vaccine were optimally efficacious. Currently over 50 000 deaths result from influenza virus infections each year in the US.1 The rate of hospitalizations owing to complications of influenza has increased steadily since 1979 and the average number for the last decade is almost 400 000 per year.2 About 85% of deaths and 63% of hospitalizations attributable to influenza occur in persons ≥65 years of age. About two-thirds of the US elderly have been vaccinated each . . . [Full Text of this Article]


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 NEJMHome page
K. L. Nichol, J. D. Nordin, D. B. Nelson, J. P. Mullooly, and E. Hak
Effectiveness of Influenza Vaccine in the Community-Dwelling Elderly
N. Engl. J. Med., October 4, 2007; 357(14): 1373 - 1381.
[Abstract] [Full Text] [PDF]

Home page
 NEJMHome page
W. P. Glezen
Influenza control.
N. Engl. J. Med., July 6, 2006; 355(1): 79 - 81.
[Full Text] [PDF]